CD80 and neoplasm: Pan Zheng and Yang Liu in 2018 have shown that the main molecular mechanism of CTLA-4 antibody drugs is to clear the local tumour Treg through the ADCC effect mediated by the Fc CTLA-4 segment, rather than by blocking CTLA-4/B7 interaction [21, 22].